Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Certara | CERT | Jul 26, 2024 | 15.72 | +1.09 |
Cerus | CERS | Jul 26, 2024 | 2.38 | 0.00 |
CervoMed | CRVO | Jul 26, 2024 | 14.03 | -2.37 |
Cetus Capital Acquisition | CETU | Jul 26, 2024 | 7.12 | +0.99 |
CEVA | CEVA | Jul 26, 2024 | 20.57 | +3.99 |
CF Acquisition VII A | CFFS | Jul 26, 2024 | 10.95 | -0.45 |
CF Bankshares | CFBK | Jul 26, 2024 | 21.55 | +0.23 |
CF Industries | CF | Jul 26, 2024 | 75.04 | +2.08 |
CFSB Bancorp | CFSB | Jul 26, 2024 | 6.84 | +0.83 |
CG Oncology | CGON | Jul 26, 2024 | 33.07 | +0.24 |
CGI | GIB | Jul 26, 2024 | 108.85 | +0.90 |
Chain Bridge I SPAC A | CBRG | Jul 26, 2024 | 11.25 | 0.00 |
Chain Bridge I Units | CBRGU | Jul 26, 2024 | 11.15 | 0.00 |
Champions Oncology | CSBR | Jul 26, 2024 | 4.90 | +1.87 |
ChampionX | CHX | Jul 26, 2024 | 34.57 | +1.44 |
Chanson International | CHSN | Jul 26, 2024 | 1.85 | -5.61 |
ChargePoint | CHPT | Jul 26, 2024 | 2.19 | +7.88 |
Charles & Colvard | CTHR | Jul 26, 2024 | 1.93 | +0.52 |
Charles River Laboratories International | CRL | Jul 26, 2024 | 233.47 | +5.26 |
Charles Schwab | SCHW | Jul 26, 2024 | 66.60 | +0.54 |
Chart Industries | GTLS | Jul 26, 2024 | 161.27 | +1.07 |
Chart Industries | GTLS-B | Jul 26, 2024 | 62.65 | -0.67 |
Charter Communications A | CHTR | Jul 26, 2024 | 367.62 | +16.62 |
Chatham Lodging Trust (REIT) A Pref | CLDT-A | Jul 26, 2024 | 21.04 | -0.85 |
Chatham Lodging Trust REIT | CLDT | Jul 26, 2024 | 8.96 | +1.24 |
Cheche Group | CCG | Jul 26, 2024 | 0.89 | -2.31 |
Check Point Software Technolgies | CHKP | Jul 26, 2024 | 182.74 | +0.87 |
Check-Cap | CHEK | Jul 26, 2024 | 2.01 | -0.50 |
Checkpoint Therapeutics | CKPT | Jul 26, 2024 | 2.57 | -3.38 |
Cheer Holding | CHR | Jul 26, 2024 | 2.55 | -1.16 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.